-
Signature
-
/s/ Ernest C. Garcia II
-
Stock symbol
-
CVNA
-
Transactions as of
-
Jul 25, 2025
-
Transactions value $
-
-$33,549,945
-
Form type
-
4
-
Date filed
-
7/29/2025, 07:44 PM
Reporting Owners (2)
Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
GARCIA ERNEST C. II |
10%+ Owner |
1720 W. RIO SALADO PARKWAY, SUITE A, TEMPE |
/s/ Ernest C. Garcia II |
2025-07-29 |
0001017608 |
ECG II SPE, LLC |
10%+ Owner |
1720 W. RIO SALADO PARKWAY, SUITE A, TEMPE |
/s/ Ernest C. Garcia II, ECG II SPE, LLC |
2025-07-29 |
0001754720 |
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
CVNA |
Class A Common Stock |
Conversion of derivative security |
|
+50K |
|
|
50K |
Jul 25, 2025 |
Direct |
F1 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$4.95M |
-14.9K |
-29.73% |
$332.95 |
35.1K |
Jul 25, 2025 |
Direct |
F2, F3 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$2.37M |
-7.1K |
-20.21% |
$334.04 |
28K |
Jul 25, 2025 |
Direct |
F2, F3 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$1.69M |
-5.04K |
-17.97% |
$335.17 |
23K |
Jul 25, 2025 |
Direct |
F2, F3 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$4.29M |
-12.8K |
-55.52% |
$336.25 |
10.2K |
Jul 25, 2025 |
Direct |
F2, F3 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$193K |
-573 |
-5.6% |
$337.29 |
9.66K |
Jul 25, 2025 |
Direct |
F2, F3 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$2.29M |
-6.76K |
-69.97% |
$338.48 |
2.9K |
Jul 25, 2025 |
Direct |
F2, F3 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$984K |
-2.9K |
-100% |
$339.35 |
0 |
Jul 25, 2025 |
Direct |
F2, F3 |
transaction |
CVNA |
Class A Common Stock |
Conversion of derivative security |
|
+50K |
|
|
50K |
Jul 28, 2025 |
Direct |
F1 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$3.42M |
-10.2K |
-20.49% |
$333.72 |
39.8K |
Jul 28, 2025 |
Direct |
F2, F4 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$3.59M |
-10.7K |
-26.99% |
$334.72 |
29K |
Jul 28, 2025 |
Direct |
F2, F4 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$4.15M |
-12.3K |
-42.54% |
$335.88 |
16.7K |
Jul 28, 2025 |
Direct |
F2, F4 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$2.78M |
-8.24K |
-49.42% |
$336.73 |
8.44K |
Jul 28, 2025 |
Direct |
F2, F4 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$2.33M |
-6.91K |
-81.92% |
$337.71 |
1.53K |
Jul 28, 2025 |
Direct |
F2, F4 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$516K |
-1.53K |
-100% |
$338.45 |
0 |
Jul 28, 2025 |
Direct |
F2, F4 |
transaction |
CVNA |
Class B Common Stock |
Other |
|
-50K |
-0.14% |
|
35.5M |
Jul 25, 2025 |
Direct |
F5 |
transaction |
CVNA |
Class B Common Stock |
Other |
|
-50K |
-0.14% |
|
35.4M |
Jul 28, 2025 |
Direct |
F5 |
holding |
CVNA |
Class B Common Stock |
|
|
|
|
|
8M |
Jul 25, 2025 |
ECG II SPE, LLC |
F6 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
CVNA |
Class A Units |
Conversion of derivative security |
$0 |
-62.5K |
-0.14% |
$0.00 |
44.4M |
Jul 25, 2025 |
Class A Common Stock |
50K |
|
Direct |
F1 |
transaction |
CVNA |
Class A Units |
Conversion of derivative security |
$0 |
-62.5K |
-0.14% |
$0.00 |
44.3M |
Jul 28, 2025 |
Class A Common Stock |
50K |
|
Direct |
F1 |
holding |
CVNA |
Class A Units |
|
|
|
|
|
10M |
Jul 25, 2025 |
Class A Common Stock |
10M |
$0.00 |
ECG II SPE, LLC |
F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: